Craniotomy Completed Phase 3 Trials for Remifentanil (DB00899)

IndicationStatusPhase
DBCOND0021273 (Craniotomy)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00741351Anesthesiological Strategies in Elective CraniotomyTreatment